A scrap of information on Amgen’s weight problems drug candidate wipes out $12 billion in marketplace price
On Tuesday, a tiny shred of information on Amgen’s lead weight problems candidate — now not but verified — erased $12 billion in marketplace price. The information, noticed via an analyst at